1 asset in Thymoma
Therapeutic assets addressing Thymoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Avelumab Thymoma | National Cancer Institute (NCI) | P2 | CCC (48) |
Therapeutic assets addressing Thymoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Avelumab Thymoma | National Cancer Institute (NCI) | P2 | CCC (48) |